Medical/Pharmaceuticals
MeditWave 2024 in Porto Brings Together Global Experts to Shape the Future of Digital Dental Solutions
PORTO, Portugal, Dec. 2, 2024 /PRNewswire/ -- On November 9, Medit, a global leader in digital dentistry solutions, hosted its two-day MeditWave 2024 in Porto, Portugal. This dynamic gathering of dental professionals from around the world fostered valuable exchanges and showcased the latest innova...
2024-12-02 22:00
1933
Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment
Follow-up to ScreenTrustCAD presented at RSNA 2024 highlights 1-year post-AI adoption success in improving cancer detection, radiologist workload, and screening efficiency SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cance...
2024-12-02 22:00
2339
Health On Cloud Showcases Innovative Healthcare Solutions at the Korea-LAC Trade and Innovation Forum, Accelerating Expansion into Latin America
SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Health On Cloud (HOC) is impactingColombia's healthcare sector through the use of digital innovations in a pilot project funded by the Inter-American Development Bank (IDB). This initiative is scheduled to expand toMexico and Brazil in the first ha...
2024-12-02 22:00
2148
European Wellness Biomedical Group, Headed by Prof. Mike Chan, Releases New Study on Bioregenerative Blueprint for Athletic Longevity
KOTA KINABALU, Malaysia, Dec. 2, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG), a global leader in regenerative medicine, has unveiled a groundbreaking study led by renowned expert Prof.Mike Chan on the physiological challenges aging athletes face. The analysis explores how age ...
2024-12-02 16:30
3764
Fangzhou Inc. Strengthens Partnerships with Tencent and Baidu, Unveiling its "AI Agent Solution"
CHENGDU, China, Dec. 2, 2024 /PRNewswire/ -- On November 22, 2024, Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, hosted the "Data and AI: Decoding Digital Engagement" summit in Chengdu, bringing together key representatives from leading Internet...
2024-12-02 15:21
2289
MGI Tech announces partnership with Universidad de San Martín de Porres to strengthen human genetics research
* The implementation of MGI Tech's next-generation genomic sequencing (NGS) technologies will strengthen scientific research in the country, enabling the identification of key genetic variations, contributing to disease prevention, and personalizing medical treatments. * A team of specialists...
2024-12-02 11:16
1795
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong
SHANGHAI, Dec. 2, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that Department of Health of the Gover...
2024-12-02 07:40
2661
When ancient cures meet smart tech: Level up your health
BEIJING, Dec. 1, 2024 /PRNewswire/ -- This is a report from China.org.cn.   Join presenter Jason Dane Castleton at the Health and Wellness pavilion of the second China International Supply Chain Expo, where innovations from traditional medicine to genetic technology are transform...
2024-12-01 19:34
3946
CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China
* CBC Group and Mubadala acquire UCB's mature neurology and allergy business inChina for US$680 million. * New company is named NeuroGen Pharma, led by an experienced management team with a strong track record in the biopharma industry. * Strategic acquisition under CBC's buyout strategy exp...
2024-11-30 09:00
6439
BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech
CHENGDU, China, Nov. 29, 2024 /PRNewswire/ -- BGM Group Ltd. (NASDAQ: BGM) ("the Company" or "BGM"), a leading global pharmaceutical enterprise, today announced its acquisition of the intelligent platform of AIX Inc. (NASDAQ: AIFU) ("AIX") valued at1 billion RMB (approximately $140 million). The ...
2024-11-29 23:58
5936
MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transitioning to oral Contezolid tablets for the treatment of adult patients with complex sk...
2024-11-29 22:00
3461
Minghui Pharmaceutical Announces Positive Topline Results from Phase Ⅲ Trial of MH004 (Tofacitinib Etocomil) Ointment in Mild to Moderate Atopic Dermatitis
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced positive topline results from its phase Ⅲ trial of MH004 (tofacitinib etocomil) ointment 1.0%, a twic...
2024-11-29 20:31
3657
"Are your Hands & Feet trying to tell you something?" - Ask leading Health Experts
* Do you feel numbness, pain, tingling or pins and needles in your hands and feet? * 8 out of 10 patients with Peripheral Neuropathy don't listen to what their nerves are telling them and go undiagnosed leading to worsening of symptoms. MANILA, Philippines, Nov. 29, 2024 /PRNewswire/ -- As pa...
2024-11-29 13:30
2415
Akeso to Present at Citi 2024 Global Healthcare Conference and the 7th Annual Evercore HealthCONx Conference
HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce its participation in the upcoming 7th Annual Evercore HealthCONx Conference and Citi 2024 Global Healthcare Conference, both taking place inMiami. Akeso will participate in a firesid...
2024-11-29 10:23
1974
Borsch Med Partners with Unity Pharmacies to Help Elderly Access Zeria Chondroitin-based Joint Health Supplements in Support of Healthy Ageing in Singapore
SINGAPORE, Nov. 29, 2024 /PRNewswire/ -- Leading health and nutrition company, Borsch Med Pte Ltd (Borch Med) has announced that Zeria chrondroitin-based joint health supplements are now available at selected Unity pharmacies in Singapore. The enhanced distribution network of the Japanese-made sup...
2024-11-29 10:00
2464
Microbio Appoints Paul Brennan as Chair of the Board
BRISBANE, Australia, Nov. 29, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has appointedPaul Brennan as Chair of the Board, effective 2nd December 2024. Paul brings extensive global experience as a Non-E...
2024-11-29 06:30
2747
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific...
2024-11-28 21:30
4450
Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecifi...
2024-11-28 21:06
4284
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients
MELBOURNE, Australia, Nov. 28, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and Grand Pharmaceutical Group Limited (00512.HK, Grand Pharma) today announce that a first patient has been dosed in the Phase III ZIRCON-CP trial of TLX250-CDx positron ...
2024-11-28 17:22
2964
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List
ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the new indication...
2024-11-28 16:59
3445
Week's Top Stories
Most Reposted
Wonder Raises USD 12 Million Venture Debt from HSBC Innovation Banking to Drive Growth and Expansion
[Picked up by 322 media titles]
2026-02-02 10:00
Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum
[Picked up by 322 media titles]
2026-01-29 15:06
AI adoption is widespread, but developer confidence is still catching up, Agoda report finds
[Picked up by 306 media titles]
2026-02-03 11:00
Colebrook Bosson Saunders Officially Launches Lana, A Circular Ergonomic Laptop Stand for the Hybrid Generation
[Picked up by 301 media titles]
2026-02-03 12:00
Singapore Airshow 2026 Milestone Edition: 20 Years of Shaping the Aerospace Landscape as Asia-Pacific Drives Global Growth
[Picked up by 286 media titles]
2026-02-01 19:35